Varicose veins, deep vein thrombosis, and hemorrhoids

1973 ◽  
Vol 85 (4) ◽  
pp. 572-573 ◽  
Author(s):  
D.P Burkitt
1998 ◽  
Vol 91 (2) ◽  
pp. 101-104 ◽  
Author(s):  
Tomio Kawasaki ◽  
Nobutoshi Shinoki ◽  
Shin-ichi Iwamoto ◽  
Hironobu Fujimura ◽  
Norihide Yoshikawa ◽  
...  

2021 ◽  
pp. 1-4
Author(s):  
Zierau UT

The thrombosis in areas of the superficial truncal varicose veins and cutaneous veins is not a rare complication; it requires drug or surgical therapy if the thrombosis grows in the direction of deep veins. This situation is particularly striking in the case of thromboses of the great saphenous vein GSV and small saphenous vein SSV as well as other saphenous veins and leads to deep vein thrombosis in around 20% of cases. We will report about a case of SSV thrombosis and the catheter-based therapy of thrombosis following the therapy of truncal varicose vein SSV with VenaSeal® in one session.


1987 ◽  
Author(s):  
P Prandoni ◽  
A W A Lensing ◽  
G Zambon ◽  
A Breda ◽  
S Cuppini ◽  
...  

Previous studies revealed a number of acquired risk factors predisposing to acute deep vein-thrombosis (DVT). Unfortunately many of these clinical or epidemiologic studies were not proper designed, since they didn't include consecutive patients, used no or different types of objective endpoints or collected the data retrospectively. In a prospective trial we evaluated 307 consecutive out-patients with clinically suspected DVT by using ascending venography, which confirmed suspicion in 136 (44%). A history of prior thrombotic episodes as well as factors predisposing to DVT including advancing age, obesity, smoking habits, cancer, chronic lung and/or heart disease, immobilization, pregnancy, childbirth, chronic liver disease, systemic lupus erythematosus (SLE), nephrotic syndrome, varicose veins, fractures or trauma or chronic arteriopathies of the legs, diabetes mellitus (DM), recent surgery and estrogen therapy were recorded in all patients. The results of our comparison of these risk factors with the outcome of venography indicate clearly a significant difference (chi-square test) between patients with and without DVT for the following: -previous documented thromboembolism, cancer (p < 0.01); -chronic lung and/or heart disease, age > 65 years, immobilization (p < 0.05). The frequency of pregnancy, childbirth, nephrotic syndrome and chronic liver disease among our patients was too low for providing sufficiently narrow confidence limits. Surprisingly the presence of varicose veins will decrease the possibility of DVT (p < 0.01). In all patients (n=3) affected by SLE clinical suspicion was confirmed. Obesity, smoking habits, recent trauma or fracture or chronic artheriopathies of the legs, DM, recent surgery and estrogen therapy were not associated with an increased risk of thrombosis, since their presence in both groups was approximately the same.


The Lancet ◽  
1976 ◽  
Vol 308 (7993) ◽  
pp. 1019-1020 ◽  
Author(s):  
MauriceJ.N. Frohn

Author(s):  
Sebastian Schellong ◽  
Walter Ageno ◽  
Ivan B. Casella ◽  
Kok Han Chee ◽  
Sam Schulman ◽  
...  

AbstractIsolated distal deep vein thrombosis (IDDVT) is presumed to be more benign than proximal DVT (PDVT) or pulmonary embolism (PE), suggesting a need for different management approaches. This subgroup analysis of the RE-COVERY DVT/PE global, observational study investigated patient characteristics, hospitalization details, and anticoagulant therapy in patients with IDDVT in real-world settings in 34 countries enrolled from January 2016 to May 2017. Data were analyzed descriptively according to the type and location of the index venous thromboembolism (VTE): IDDVT, PDVT ± distal DVT (DDVT), and PE ± DVT. Of the 6,095 eligible patients, 323 with DVT located outside the lower limb and no PE were excluded. Of the remaining 5,772 patients, 17.6% had IDDVT, 39.9% had PDVT ± DDVT, and 42.5% had PE ± DVT. IDDVT patients were younger and had fewer risk factors for VTE than the other groups. Other comorbidities were less frequent in the IDDVT group, except for varicose veins, superficial thrombophlebitis, and venous insufficiency. IDDVT patients were less likely to be diagnosed in an emergency department (22.3 vs. 29.7% for PDVT ± DDVT and 45.4% for PE ± DVT) or hospitalized for VTE (29.2 vs. 48.5% for PDVT ± DDVT and 75.0% for PE ± DVT). At hospital discharge or 14 days after diagnosis (whichever was later), non–vitamin K antagonist oral anticoagulants were the most commonly used anticoagulants (55.6% for IDDVT, 54.7% for PDVT ± DDVT, and 52.8% for PE ± DVT). Although differences in patient characteristics, risk factors, and clinical management were identified, anticoagulant treatment of IDDVT was almost equal to that of PDVT or PE. Prospective studies should investigate whether, in a global perspective, this is an appropriate use of anticoagulants. Trial registration number ClinicalTrials.gov NCT02596230.


2020 ◽  
pp. 86-89
Author(s):  
V. A. Prasol ◽  
K. V. Myasoyedov ◽  
I. V. Guyvan

Summary. One of the most common complications of varicose veins is lower varicotrombophlebitis, which occurs in 30-59 % of cases and is an em bolo genic risk. Aim. The aim of our study is to evaluate the effectiveness of using the method of endothermic treatment of the mouth of a large subcutaneous vein in patients in the acute period of varicotrombophlebitis. Materials and methods of research. The data of 58 patients treated for acute varicotrombophlebitis in State Institution “Institute of Generaland Emergency Surgery”. V. T. Zaitseva NAMS of Ukraine”, Kharkov in 2018-2020. Research results. With ultra sound control in the main group on the 1st post operative day in 100 % of cases, obliteration of the proximal segment of the large subcutaneous veins with the saphenofemoral mouth. After 1 month on ultrasound in the comparison group complete recanalization o VPV trunk, and in the comparison group obliteration of the proximal segment of the VPV in the p/3 thighs, distally was noted recanalization of the VPV. Conclusions. We consider endothermic treatment of a large saphenous vein in patients with acute varicotrombophlebitis to avoid complications such as deep vein thrombosis or pulmonary.


2017 ◽  
Vol 13 (3) ◽  
pp. 317-326
Author(s):  
Zbigniew Krasiński ◽  
◽  
Krzysztof Aniukiewicz ◽  
Aleksandra Krasińska ◽  
Beata Krasińska ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document